Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto


   0 (0%) 12-31 19:00
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0(M)

Technical analysis

as of: 2023-02-02 4:28:48 PM
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Target: Six months: 142.02     One year: 165.88
Support: Support1: 108.37    Support2: 100.19
Resistance: Resistance1: 121.59    Resistance2: 142.02
Pivot: 115.58
Moving Average: MA(5): 112.82     MA(20): 114.73
MA(100): 110.52     MA(250): 106.9
MACD: MACD(12,26): 1     Signal(9): 0.9
Stochastic oscillator: %K(14,3): 71.5     %D(3): 53
RSI: RSI(14): 57.6
52-week: High: 127.73  Low: 79.92
Average Vol(K): 3-Month: 98 (K)  10-Days: 142 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ APPF ] has closed below upper band by 25.3%. Bollinger Bands are 12% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 121.61 - 122.04 122.04 - 122.42
Low: 111.86 - 112.38 112.38 - 112.85
Close: 118.6 - 119.36 119.36 - 120.05

Company Description

Headline News

Thu, 02 Feb 2023
IOC details Russia stance for Olympics, cites human rights - New Canaan Advertiser

Thu, 02 Feb 2023
Automotive Test Equipment Market Statistical Forecast, Trade ... - Trending in Pakistan

Thu, 02 Feb 2023
Glenville shelter welcomes homeless pets from Louisiana - NEWS10 ABC

Tue, 31 Jan 2023
Waste not, want not: Aptar creates metal-free nasal spray pump to ... - FiercePharma

Tue, 31 Jan 2023
FDA extends review of argenx's subcutaneous efgartigimod ... - FiercePharma

Tue, 31 Jan 2023
Asset Purchase Facility Quarterly Report - 2022 Q4 - Bank of England

Financial Analysis

Price to Book Value: Neutral
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Neutral
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Neutral
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Shares Out. 20 (M)
Shares Float 17 (M)
% Held by Insiders 8.1 (%)
% Held by Institutions 79.3 (%)
Shares Short 524 (K)
Shares Short P.Month 534 (K)

Stock Financials

EPS -0.41
EPS Est Next Qtl 0.05
EPS Est This Year 0.31
EPS Est Next Year 0.43
Book Value (p.s.) 7.53
Profit Margin (%) -14.5
Operating Margin (%) -10.7
Return on Assets (ttm) -8
Return on Equity (ttm) -24.3
Qtrly Rev. Growth 29.7
Gross Profit (p.s.) 13.72
Sales Per Share 23.12
EBITDA (p.s.) -0.96
Qtrly Earnings Growth 0
Operating Cash Flow 25 (M)
Levered Free Cash Flow 30 (M)

Stock Valuations

PE Ratio -298.65
PEG Ratio 19.1
Price to Book value 15.84
Price to Sales 5.16
Price to Cash Flow 96.14

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.